Rheological alterations and thrombotic events in patients with systemic lupus erythematosus

被引:13
|
作者
Vaya, Amparo [1 ]
Calvo, Javier [2 ]
Alcala, Carmen [1 ]
Mico, Luisa [3 ]
Todoli, Jose [3 ]
Ricart, Jose M. [4 ]
机构
[1] La Fe Univ Hosp, Hemorheol & Hemostasis Unit, Serv Clin Pathol, Valencia 46009, Spain
[2] Gen Hosp, Rheumatol Serv, Valencia, Spain
[3] La Fe Univ Hosp, Internal Med Serv, Valencia 46009, Spain
[4] La Fe Univ Hosp, Dermatol Serv, Valencia 46009, Spain
关键词
Systemic lupus erythematosus; thrombosis; hemorheology; WHOLE-BLOOD VISCOSITY; ERYTHROCYTE AGGREGATION; PLASMA;
D O I
10.3233/CH-2011-1508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) is characterised by increased venous and arterial thrombotic risk. Nevertheless, how hemorheological alterations contribute to thrombotic risk remains a question of debate. We aimed to determine the rheological profile in 105 patients with SLE (24 with a thrombotic event) and 105 healthy controls. We determined blood viscosity and erythrocyte aggregation along with plasma lipids and fibrinogen. Although SLE patients showed lower blood viscosity at 230 s(-1) at a native hematocrit when compared with controls (p < 0.001), differences disappeared after adjusting the hematocrit to 45% (p = 0.095). When comparing SLE patients with and without thrombotic events, no differences in any rheological parameter were found (p > 0.05), except in fibrinogen which was higher in patients with thrombosis (p = 0.013). No differences in the rheological parameters were observed when venous and arterial thrombotic events were compared, although a tendency for higher fibrinogen was observed in patients with venous thrombosis (p = 0.053). Only hematocrit, fibrinogen and triglycerides were independent predictors of native blood viscosity in the multivariate regression analysis, even after adjusting for continuous variables and for tobacco and hypertension: beta coefficient: 0.727 p < 0.001; beta coefficient: 0.152 p = 0.003 and beta coefficient: 0.133 p = 0.015, respectively. The logistic regression analysis revealed that neither increased native blood viscosity (BVn > 4.33) nor increased erythrocyte aggregation (EA1 > 7.85) increased thrombotic risk: OR 0.636, CI 0.313-3.12, p = 0.578 and OR 2.01, CI 0.77-5.20, p = 0.152, respectively. However, hyperfibrinogenemia (Fbg > 342 mg/dL) increased thrombotic risk by around three times: OR 3.44 CI 1.32-8.96, p = 0.011. Our results suggest that the role of blood viscosity and erythrocyte aggregation in thrombotic risk in SLE patients fails to demonstrate any association.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [31] Pulmonary and thrombotic manifestations of systemic lupus erythematosus
    Swigris, Jeffrey J.
    Fischer, Aryeh
    Gilles, Joann
    Meehan, Richard T.
    Brown, Kevin K.
    CHEST, 2008, 133 (01) : 271 - 280
  • [32] Thrombotic thrombocytopenic purpura at presentation of juvenile systemic lupus erythematosus patients
    Campos, Lucia M. A.
    Spadoni, Maria Silvia
    Michelin, Cintia M.
    Jesus, Adriana A.
    Cameiro, Jorge D. A.
    Almeida da Silva, Clovis Artur
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (01) : 120 - 126
  • [33] THROMBOTIC MICROANGIOPATHY IN RENAL BIOPSIES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Gerhardsson, J.
    Zickert, A.
    Sundelin, B.
    Svenungsson, E.
    Gunnarsson, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 210 - 210
  • [34] ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA IN PATIENTS WITH AND WITHOUT SYSTEMIC LUPUS ERYTHEMATOSUS
    Yue, Cai
    Su, Jian
    Zhang, Xuan
    Li, Xuemei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 96 - 96
  • [35] ELECTROCARDIOGRAPHIC ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND CONTROLS.
    Balderas-Palacios, M. A.
    Azpiri-Lopez, J. R.
    Galarza-Delgado, D. A.
    Colunga-Pedraza, I. J.
    Rodriguez-Romero, A. B.
    Cardenas, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1387 - 1387
  • [36] Immune profile alterations of systemic lupus erythematosus patients with infections
    Zhi, Langxian
    Gu, Liyang
    Tong, Lei
    Liu, Xuesong
    Lu, Liangjing
    Guo, Ruru
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4765 - 4777
  • [37] Immune profile alterations of systemic lupus erythematosus patients with infections
    Langxian Zhi
    Liyang Gu
    Lei Tong
    Xuesong Liu
    Liangjing Lu
    Ruru Guo
    Clinical and Experimental Medicine, 2023, 23 : 4765 - 4777
  • [38] Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus
    He, Zhixing
    Shao, Tiejuan
    Li, Haichang
    Xie, Zhijun
    Wen, Chengping
    GUT PATHOGENS, 2016, 8
  • [39] Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus
    Zhixing He
    Tiejuan Shao
    Haichang Li
    Zhijun Xie
    Chengping Wen
    Gut Pathogens, 8
  • [40] Incidence and risk of arterial and venous thrombotic events in systemic lupus erythematosus patients: a population-based study
    Ojeda-Fernandez, Luisa
    Calvisi, Stefania
    Torrigiani, Ginevra
    Tettamanti, Mauro
    Fortino, Ida
    Roncaglioni, Carla
    Baviera, Marta
    RHEUMATOLOGY, 2024,